nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-3219279E·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.3 Health sciences·Subfield: Nutrition and Dietetics·Basis: Full text·Type: Observational cohort study

Human Milk Oligosaccharides in Maternal Serum Respond to Oral Glucose Load and Are Associated with Insulin Sensitivity.

Weiser-Fuchs et al.Weiser-Fuchs, Maggauer, van Poppel et al.·2023·Nutrients·10.3390/nu15184042 ↗

Primary claim

Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.

Tentative · the repeated time course supports the 3′SL rise, but significant LDFT and 3′SLN changes contradict the unchanged-other-HMOs clause
In brief

Repeated pregnancy OGTT sampling identifies an acute serum 3′SL rise, but uncontrolled analyses leave its proposed metabolic mechanism unestablished.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

(1) Background: Pregnancy presents a challenge to maternal glucose homeostasis; suboptimal adaptations can lead to gestational diabetes mellitus (GDM). Human milk oligosaccharides (HMOs) circulate in maternal blood in pregnancy and are altered with GDM, suggesting influence of glucose homeostasis on HMOs. We thus assessed the HMO response to glucose load during an oral glucose tolerance test (OGTT) and investigated HMO associations with glucose tolerance/insulin sensitivity in healthy pregnant women. (2) Methods: Serum of 99 women, collected at 0 h, 1 h and 2 h during a 75 g OGTT at 24-28 gestational weeks was analyzed for HMOs (2'FL, 3'SLN, LDFT, 3'SL) by HPLC; plasma glucose, insulin and C-peptide were analyzed by standard biochemistry methods. (3) Results: Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered. Higher 3'SL at all OGTT time points was associated with a generally more diabetogenic profile, with higher hepatic insulin resistance (HOMA-IR), lower insulin sensitivity (Matsuda index) and higher insulin secretion (C-peptide index 1). (4) Conclusions: Rapid increase in serum 3'SL post-oral glucose load (fasted-fed transition) indicates utilization of plasma glucose, potentially for sialylation of lactose. Associations of sialylated HMOs with a more diabetogenic profile suggest sustained adaptations to impaired glucose homeostasis in pregnancy. Underlying mechanisms or potential consequences of observed HMO changes remain to be elucidated.

Key Claims

Primary finding · Tentative

Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

the repeated time course supports the 3′SL rise, but significant LDFT and 3′SLN changes contradict the unchanged-other-HMOs clause

Abstract, Results
Quote verified
Secondary · Tentative

Higher 3'SL at all OGTT time points was associated with a generally more diabetogenic profile, with higher hepatic insulin resistance (HOMA-IR), lower insulin sensitivity (Matsuda index) and higher insulin secretion (C-peptide index 1).

unadjusted observational correlations leave adiposity confounding unresolved across numerous metabolic comparisons

Abstract, Results
Quote verified
Secondary · Tentative

Rapid increase in serum 3'SL post-oral glucose load (fasted-fed transition) indicates utilization of plasma glucose, potentially for sialylation of lactose.

an uncontrolled concentration time course without mechanistic measurements cannot identify glucose incorporation or lactose sialylation

Abstract, Conclusions
Quote verified
Secondary · Tentative

AUC (0 h to 2 h) of 3′SL and 3′SLN was significantly higher (p = 0.0002 and p = 0.0381, respectively) in Cluster 1 compared to Cluster 2

data-derived clusters without adiposity adjustment or multiplicity control leave the reported comparisons exploratory

Section 3.4, Figure 3
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Acute serum dynamics extend pregnancy HMO research

Measuring HMOs before and after a routine glucose challenge adds a short-timescale physiological observation to earlier studies of pregnancy metabolic status.

↳ Introduction; Sections 3.2 and 4.1

#methodological rigour

Standardized sampling supports within-person time course

The study samples 99 women at fasting, one hour, and two hours during a standardized OGTT. HPLC standards and internal normalization support comparison of the measured HMO concentrations.

↳ Sections 2.3–2.5 and 3.2

#positioning

Discussion engages competing biological evidence explicitly

The discussion contrasts acute serum changes with lactation studies suggesting slower dietary effects and identifies missing lactose and sialic acid measurements as barriers to testing the proposed pathway.

↳ Sections 4.1 and 4.4

Limitations

#reporting

Abstract misstates which oligosaccharides changed significantly

The abstract says HMOs other than 3′SL were unaltered, but Section 3.2 reports an LDFT increase (p = 0.015) and a 3′SLN decrease (p = 0.014). The observed 3′SL rise therefore is not the only reported HMO change.

↳ Abstract, Results; Section 3.2

#methodological rigour

Unadjusted associations and unexplained exclusions limit inference

Metabolic associations rely on unadjusted correlations despite substantial BMI and adiposity differences between clusters, alongside extensive multiple testing. The clusters include 89 of 99 participants, with only one of ten exclusions explained.

↳ Sections 2.7 and 3.3–3.5

#methodological rigour

Concentration changes do not establish glucose utilization

The abstract infers glucose utilization for lactose sialylation from an uncontrolled time course. Without direct mechanistic measurements or a time-matched non-glucose control, the concentration rise does not identify the proposed biosynthetic pathway.

↳ Abstract, Conclusions; Sections 2.3, 4.1, and 4.4

Does this match your read? Add your assessment ↓

Nabu Commentary

Standardized OGTT sampling and internal-standard HPLC provide a focused observation of an acute serum 3′SL rise during mid-pregnancy. The metabolic interpretation is less secure because correlations are unadjusted despite pronounced adiposity differences, and extensive testing makes borderline associations difficult to interpret. Concentration changes alone do not establish the glucose-utilization mechanism asserted in the abstract, even though the discussion acknowledges missing mechanistic measurements. The abstract also incorrectly describes the other HMOs as unchanged, while unexplained cluster exclusions and unit and label errors reduce reporting precision.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.8±0.1

Contribution
3.6

Repeated serum HMO measurements during a routine pregnancy OGTT add a focused physiological observation to earlier pregnancy HMO–metabolism associations. The contribution remains descriptive rather than establishing a biosynthetic mechanism.

Introduction; Sections 3.2–3.3 and 4.1
Methodological Rigour
2.0

Standardized repeated sampling, internal-standard HPLC, and metabolic phenotyping support the observed time course, but uncontrolled confounding and mechanistic inference substantially limit interpretation. The abstract–results contradiction and unresolved cluster reporting are separately surfaced in the reliability flag.

Sections 2.3–2.7, 3.2–3.5, and 4.4; Abstract, Conclusions
Reporting
3.0

The manuscript follows its research questions coherently, but the abstract misstates the specificity of the HMO response. Unit errors, variable mislabelling, and the imprecise AUC description impede checking.

Abstract, Results; Sections 2.7, 3.2–3.3
Positioning
3.3

The discussion relates the findings to pregnancy metabolism, sialylation, and contrasting lactation literature while acknowledging absent mechanistic measurements. It does not adequately trace adiposity confounding or unexplained cluster exclusions into the interpretation.

Sections 4.1–4.4

Lower confidence on Contribution, Positioning — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered: "concentrations of the other HMOs were unaltered" (Abstract, Results) vs "LDFT concentrations increased slightly but significantly (p = 0.015) from baseline to one hour" (Section 3.2). The abstract's assertion of unchanged other HMOs conflicts with Section 3.2 reporting significant increases in LDFT and decreases in 3′SLN. → Not supported by the paper's own data
  • AUC (0 h to 2 h) of 3′SL and 3′SLN was significantly higher (p = 0.0002 and p = 0.0381, respectively) in Cluster 1 compared to Cluster 2: "Cluster 1 comprised 28, and Cluster 2 comprised 61 individuals from the study population" (Section 3.4, cluster sizes) vs "Subjects (n = 99) selected for this study were participants of the HMO study" (Section 2.1). The clusters contain 28 + 61 = 89 participants, ten fewer than the cohort of 99, while only one exclusion is explained. → Effect on result unclear
  • Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered: "3′SL, as its median concentrations increased from fasting (0.89 nmol/mL; IQR 0.62–1.1 nmol/mL) to 1 h (1.00 mmol/mL; IQR 0.78–1.21 nmol/mL)" (Section 3.2). The printed median of 1.00 mmol/mL converts to 1,000,000 nmol/mL and therefore lies outside the printed IQR of 0.78–1.21 nmol/mL. → Effect on result unclear
Reporting and transparencyNoted

Ethics approval and written consent are declared. The Results label correlations introduced as 3′SLN correlations with 3′SL identifiers.

Ethics approval: declared

Reference IntegrityClean

63 of 63 checkable references verified

63 references in manuscript

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Metabolic and endocrine · Diabetes mellitus
Type of advanceEmpirical
Route to useSuggested
AdvanceAdvances
BeneficiariesLarge
CitationsFWCI 0.6
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on a single observational cohort of 99 women with within-subject OGTT measurements, with no controlled experiment or independent confirmation.

From the paper
“Implementation of HMO measurements with the measurements of glucose during an OGTT could be valuable, especially early in pregnancy.”

The paper proposes its HMO findings could serve as biomarkers measured alongside OGTT glucose, but names no actor or setting that would use them.

Pathway

Clinicians in prenatal care could measure serum 3'SL alongside OGTT glucose as an early biomarker of glucose dysregulation and GDM risk.

Barrier

Mechanisms and consequences of the HMO changes are unknown, and the small mostly healthy cohort with few GDM cases requires validation in larger independent populations.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestine

    Neumann, Mahnert, Kumpitsch, et al. · 2023 · Clinical medicine

    Primary claim

    We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

    Tentative
    Evidence Score
    2.7±0.1
    Reliability
    Caveats
  2. Hospital Regimens Including Probiotics Guide the Individual Development of the Gut Microbiome of Very Low Birth Weight Infants in the First Two Weeks of Life

    Kurath-Koller, Neumann, Moissl-Eichinger, et al. · 2020 · Clinical medicine

    Primary claim

    We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.

    Tentative
    Evidence Score
    2.5±0.1
    Reliability
    Caveats
  3. Maternal C-Peptide and Insulin Sensitivity, but Not BMI, Associate with Fatty Acids in the First Trimester of Pregnancy

    Bandres-Meriz, Majali-Martinez, Hoch, et al. · 2021 · Clinical medicine

    Primary claim

    Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA

    Supported
    Evidence Score
    3.2±0.2
    Reliability
    Caveats

How the rubric works →